Catalyst Wire Dossier Catalyst Wire Dossier

HSV-tk gene therapy

· The Methodist Hospital Research Institute
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HSV-tk gene therapy, covering 2016-07-01 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM [Phase 1, Phase 2]

See pricing